(Q43011798)

English

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma

scientific article published in September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

based on heuristic

inferred from title

Alona Muzikansky

7

object named as

Alona Muzikansky

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

author name string

Jeremy S Abramson

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Matthew Hellmann

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Jeffrey A Barnes

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Peter Hammerman

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Christiana Toomey

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tak Takvorian

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Ephraim P Hochberg

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

116

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

4283-4290

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516 -- the Southwest Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Testicular lymphoma is associated with a high incidence of extranodal recurrence

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary breast lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary non-Hodgkin lymphoma of the breast: The Mayo Clinic Experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lympho

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

CNS involvement in primary mediastinal large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25278

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25278

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43011798&oldid=1976557578"